|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||223.26 - 223.26|
|52-week range||223.26 - 223.26|
|Beta (5Y monthly)||0.78|
|PE ratio (TTM)||N/A|
|Earnings date||31 Jan 2022 - 04 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Bruker's (BRKR) FluoroType SARS-CoV-2 varID Q assay is anticipated to provide reliable detection of the novel Omicron (B.1.1.529) variant of SARS-CoV-2.
The Studio Pro 4.0 launched by Henry Schein's (HSIC) orthodontics business will enable Reveal Clear Aligners providers to personalize treatment plans with greater ease and control.
McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.